Bruker Molecular

Bruker Molecular is a leading provider of molecular diagnostics solutions, designed to meet the diverse and growing needs of laboratories worldwide.

Headquartered in Turin, Italy, it serves as a key center for manufacturing, logistics, and business operations, making it one of the most prominent molecular biology hubs in Europe.

Over the years, Bruker Molecular has developed a comprehensive suite of PCR technologies, including the revolutionary Minor Groove Binder (MGB).

In 2016, Bruker Molecular revolutionized molecular diagnostics with the introduction of ELITe InGenius, its first fully automated sample-to-result (S2R) system.

Since then, the company has continued to expand the platform’s capabilities, offering nearly 60 CE-IVD parameters and validating over 20 different sample matrices.

Building on this success, Bruker Molecular launched ELITe BeGenius in 2021, its second S2R platform, further solidifying its commitment to delivering superior workflow efficiency and guaranteed performance. With a robust pipeline of assays, instruments, and software, the company ensures that laboratories remain at the cutting edge of molecular diagnostics.

All its products meet the highest global quality and regulatory standards and are fully compliant with the latest IVD regulations.

Bruker Molecular is certified by DEKRA Certification BV and operates under a stringent quality management system in compliance with ISO 9001:2015 and EN ISO 13485:2016 standards according to the Medical Device Single Audit Program (MDSAP).

In addition to its extensive product portfolio, Bruker Molecular provides expert technical support, including training, on-site assistance, and customized solutions from sample to result, ensuring that laboratories receive the highest level of service and performance.